Journal Mobile Options
Table of Contents
Vol. 25, No. 4, 2008
Issue release date: April 2008

Depressive Symptoms, Vascular Risk Factors and Mild Cognitive Impairment

The Italian Longitudinal Study on Aging

Panza F. · D’Introno A. · Colacicco A.M. · Capurso C. · Del Parigi A. · Caselli R.J. · Todarello O. · Pellicani V. · Santamato A. · Scapicchio P. · Maggi S. · Scafato E. · Gandin C. · Capurso A. · Solfrizzi V.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Aims: We evaluated the impact of depressive symptoms on the rate of incident mild cognitive impairment (MCI) after a 3.5-year follow-up, and we assessed the interaction between depressive symptoms and vascular risk factors for incident MCI. Methods: A total of 2,963 individuals from a sample of 5,632 65- to 84-year-old subjects were cognitively and functionally evaluated at the 1st and 2nd surveys of the Italian Longitudinal Study on Aging, a prospective cohort study with a 3.5-year follow-up. MCI and dementia were classified using current clinical criteria. Depressive symptoms were measured with the Geriatric Depression Scale. Results: Among the 2,963 participants, 139 prevalent MCI cases were diagnosed at the 1st survey. During the 3.5-year follow-up, 105 new events of MCI were diagnosed. We did not observe any significant association between depressive symptoms and incident MCI (RR = 1.25, 95% CI = 0.85–1.84, χ2 = 1.30, p < 0.25). No sociodemographic variables or vascular risk factors modified the relationship between depressive symptoms and incident MCI. Conclusion: In our population, depressive symptoms were not associated with the rate of incident MCI. Our findings did not support a role of sociodemographic variables or vascular risk factors in the link between depressive symptoms and incident MCI.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Larrieu S, Letenneur L, Orgogozo JM, Fabrigoule C, Amieva H, Le Carret N, Barberger-Gateau P, Dartigues JF: Incidence and outcome of mild cognitive impairment in a population-based prospective cohort. Neurology 2002;59:1594–1599.
  2. Gallo JJ, Lebowitz BD: The epidemiology of common late-life mental disorders in the community: themes for the new century. Psychiatr Serv 1999;50:1158–1166.
  3. Royall DR, Chiodo LK, Polk MJ: Misclassification is likely in the assessment of mild cognitive impairment. Neuroepidemiology 2004;23:185–191.
  4. Visser PJ, Verhey FR, Ponds RW, Kester A, Jolles J: Distinction between preclinical Alzheimer’s disease and depression. J Am Geriatr Soc 2000;48:479–484.
  5. Berger AK, Fratiglioni L, Forsell Y, Winblad B, Bäckman L: The occurrence of depressive symptoms in the preclinical phase of AD: a population-based study. Neurology 1999;53:1998–2002.
  6. Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S: Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: results from the cardiovascular health study. JAMA 2002;288:1475–1483.
  7. Forsell Y, Palmer K, Fratiglioni L: Psychiatric symptoms/syndromes in elderly persons with mild cognitive impairment: data from a cross-sectional study. Acta Neurol Scand Suppl 2003;179:25–28.
  8. Chan DC, Kasper JD, Black BS, Rabins PV: Prevalence and correlates of behavioral and psychiatric symptoms in community-dwelling elders with dementia or mild cognitive impairment: the Memory and Medical Care Study. Int J Geriatr Psychiatry 2003;18:174–182.
  9. Steffens DC, Otey E, Alexopoulos GS, Butters MA, Cuthbert B, Ganguli M, Geda YE, Hendrie HC, Krishnan RR, Kumar A, Lopez OL, Lyketsos CG, Mast BT, Morris JC, Norton MC, Peavy GM, Petersen RC, Reynolds CF, Salloway S, Welsh-Bohmer KA, Yesavage J: Perspectives on depression, mild cognitive impairment, and cognitive decline. Arch Gen Psychiatry 2006;63:130–138.
  10. Boeve B, McCormick J, Smith G, Ferman T, Rummans T, Carpenter T, Ivnik R, Kokmen E, Tangalos E, Edland S, Knopman D, Petersen R: Mild cognitive impairment in the oldest old. Neurology 2003;60:477–480.
  11. Fisk JD, Merry HR, Rockwood K: Variations in case definition affect prevalence but not outcomes of mild cognitive impairment. Neurology 2003;61:1179–1184.
  12. Busse A, Bischkopf J, Riedel-Heller SG, Angermeyer MC: Mild cognitive impairment: prevalence and incidence according to different diagnostic criteria – results of the Leipzig Longitudinal Study of the Aged (LEILA75+). Br J Psychiatry 2003;182:449–454.
  13. Solfrizzi V, Colacicco AM, D’Introno A, Capurso C, Del Parigi A, Capurso SA, Argentieri G, Capurso A, Panza F: Dietary fatty acids intakes and rate of mild cognitive impairment: the Italian Longitudinal Study on Aging. Exp Gerontol 2006;41:619–627.
  14. World Health Organization: International Statistical Classification of Diseases and Related Health Problems, 10th revision (ICD-10). Chapter V, categories F00–F99: Mental, behavioural, and developmental disorders, clinical description and diagnostic guidelines. Geneva, World Health Organization, 1992.
  15. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM: Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer’s disease. Neurology 1984;34:939–944.
  16. Hamilton M: A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;23:56–62.
  17. Pfeffer RI, Kurosaki TT, Harrah CH Jr, Chance JM, Filos S: Measurement of functional activities in older adults in the community. J Gerontol 1982;37:323–329.
  18. Roth M, Tym E, Mountjoy CQ, Huppert FA, Hendrie H, Verma S, Goddard R: CAMDEX: a standardised instrument for the diagnosis of mental disorders in the elderly with special reference to the early detection of dementia. Br J Psychiatry 1986;149:698–709.
  19. Baldereschi M, Zucchetto M, Grigoletto F, ILSA Working Group: Sensivity, specificity, and predictivity of an Italian version of the Mini-Mental State Examination (abstract). Ital J Neurol Sci 1993;7(suppl 14):59.
  20. American Psychiatric Association Committee on Nomenclature and Statistics: Diagnostic and Statistical Manual of Mental Disorders, ed 3, rev (DSM-III-R). Washington, American Psychiatric Association, 1987, pp 103–107.
  21. Lawton MP, Brody EM: Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179–186.
  22. Katz S, Akpom CA: A measure of primary sociobiological functions. Int J Health Serv 1976;6:493–507.
  23. Spinnler H, Tognoni G: Standardizzazione e taratura italiana di test neuropsicologici. Ital J Neurol Sci 1987;6(suppl 8):1–20.
  24. Babcock H: An experiment in the measurement of mental deterioration. Arch Psychol 1930;117:105.
  25. Folstein MF, Folstein SE, McHugh PR: Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189–198.
  26. Brink TL, Yesavage JA, Lum O, Heersema P, Adey MB, Rose TL: Screening tests for geriatric depression. Clin Gerontologist 1982;1:37–44.
  27. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, Leirer VO: Development and validation of a geriatric depression screening scale: a preliminary report. J Psychiatr Res 1982–1983;17:37–49.

    External Resources

  28. Solfrizzi V, Panza F, Colacicco AM, Capurso C, D’Introno A, Torres F, Baldassarre G, Capurso A: Relation of lipoprotein(a) as coronary risk factor to type 2 diabetes mellitus and low-density lipoprotein cholesterol in patients ≥65 years of age (the Italian Longitudinal Study on Aging). Am J Cardiol 2002;89:825–829.
  29. Italian Longitudinal Study on Aging Working Group: Prevalence of chronic diseases in older Italians: comparing self-reported and clinical diagnoses. Int J Epidemiol 1997;26:995–1002.
  30. Rozzini L, Chilovi BV, Trabucchi M, Padovani A: Depression is unrelated to conversion to dementia in patients with mild cognitive impairment. Arch Neurol 2005;62:505.
  31. Modrego PJ, Ferrandez J: Depression in patients with mild cognitive impairment increases the risk of developing dementia of Alzheimer type: a prospective cohort study. Arch Neurol 2004;61:1290–1293.
  32. Lopez OL, Jagust WJ, Dulberg C, Becker JT, DeKosky ST, Fitzpatrick A, Breitner J, Lyketsos C, Jones B, Kawas C, Carlson M, Kuller LH: Risk factors for mild cognitive impairment in the Cardiovascular Health Study Cognition Study: part 2. Arch Neurol 2003;60:1394–1399.
  33. Alexopoulos GS: Vascular disease, depression, and dementia. J Am Geriatr Soc 2003;51:1178–1180.
  34. Vermeer SE, Prins ND, den Heijer T, Hofman A, Koudstaal PJ, Breteler MM: Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med 2003;348:1215–1222.
  35. Rao R: Cerebrovascular disease and late life depression: an age old association revisited. Int J Geriatr Psychiatry 2000;15:419–433.
  36. Krishnan KR, Hays JC, Blazer DG: MRI-defined vascular depression. Am J Psychiatry 1997;154:497–501.
  37. Alexopoulos GS, Meyers BS, Young RC, Kakuma T, Silbersweig D, Charlson M: Clinically defined vascular depression. Am J Psychiatry 1997;154:562–565.
  38. Panza F, D’Introno A, Colacicco AM, Capurso C, Parigi AD, Capurso SA, Caselli RJ, Pilotto A, Scafato E, Capurso A, Solfrizzi V: Cognitive frailty: predementia syndrome and vascular risk factors. Neurobiol Aging 2006;27:933–940.
  39. DeCarli C, Miller BL, Swan GE, Reed T, Wolf PA, Carmelli D: Cerebrovascular and brain morphologic correlates of mild cognitive impairment in the National Heart, Lung, and Blood Institute Twin Study. Arch Neurol 2001;58:643–647.
  40. Kivipelto M, Helkala EL, Hanninen T, Laakso MP, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A: Midlife vascular risk factors and late-life mild cognitive impairment: a population-based study. Neurology 2001;56:1683–1689.
  41. Panza F, Capurso C, D’Introno A, Colacicco AM, Zenzola A, Menga R, Pistoia G, Santamato A, Scafato E, Gandin C, Capurso A, Solfrizzi V, Italian Longitudinal Study on Aging Working Group: Impact of depressive symptoms on the rate of progression to dementia in patients affected by mild cognitive impairment: the Italian Longitudinal Study on Aging. Int J Geriatr Psychiatry; doi: 10.1002/gps.1967.
  42. Solfrizzi V, D’Introno A, Colacicco AM, Capurso C, Del Parigi A, Caselli RJ, Scapicchio PL, Scafato E, Gandin C, Capurso A, Panza F, Italian Longitudinal Study on Aging Working Group: Incident occurrence of depressive symptoms among patients with mild cognitive impairment: the Italian Longitudinal Study on Aging. Dement Geriatr Cogn Disord 2007;24:55–64.
  43. Vinkers DJ, Gussekloo J, Stek ML, Westendorp RG, van der Mast RC: Temporal relation between depression and cognitive impairment in old age: prospective population-based study. BMJ 2004;329:881.
  44. Palsson S, Aevarsson O, Skoog I: Depression, cerebral atrophy, cognitive performance and incidence of dementia: population study of 85-year-olds. Br J Psychiatry 1999;174:249–253.
  45. Holtzer R, Scarmeas N, Wegesin DJ, Albert M, Brandt J, Dubois B, Hadjigeorgiou GM, Stern Y: Depressive symptoms in Alzheimer’s disease: natural course and temporal relation to function and cognitive status. J Am Geriatr Soc 2005;53:2083–2089.
  46. Ganguli M, Du Y, Dodge HH, Ratcliff GG, Chang CC: Depressive symptoms and cognitive decline in late life: a prospective epidemiological study. Arch Gen Psychiatry 2006;63:153–160.
  47. Dufouil C, Fuhrer R, Dartigues JF, Alperovitch A: Longitudinal analysis of the association between depressive symptomatology and cognitive deterioration. Am J Epidemiol 1996;144:634–641.
  48. Chen P, Ganguli M, Mulsant BH, DeKosky ST: The temporal relationship between depressive symptoms and dementia: a community-based prospective study. Arch Gen Psychiatry 1999;56:261–266.
  49. Yaffe K, Blackwell T, Gore R, Sands L, Reus V, Browner WS: Depressive symptoms and cognitive decline in nondemented elderly women: a prospective study. Arch Gen Psychiatry 1999;56:425–430.
  50. Wilson RS, Barnes LL, Mendes de Leon CF, Aggarwal NT, Schneider JS, Bach J, Pilat J, Beckett LA, Arnold SE, Evans DA, Bennett DA: Depressive symptoms, cognitive decline, and risk of AD in older persons. Neurology 2002;59:364–370.
  51. Geda YE, Knopman DS, Mrazek DA, Jicha GA, Smith GE, Negash S, Boeve BF, Ivnik RJ, Petersen RC, Pankratz VS, Rocca WA: Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: a prospective cohort study. Arch Neurol 2006;63:435–440.
  52. Gatz JL, Tyas SL, St John P, Montgomery P: Do depressive symptoms predict Alzheimer’s disease and dementia? J Gerontol A Biol Sci Med Sci 2005;60:744–747.
  53. Fuhrer R, Dufouil C, Dartigues JF, PAQUID Study: Exploring sex differences in the relationship between depressive symptoms and dementia incidence: prospective results from the PAQUID Study. J Am Geriatr Soc 2003;51:1055–1063.
  54. Dal Forno G, Palermo MT, Donohue JE, Karagiozis H, Zonderman AB, Kawas CH: Depressive symptoms, sex, and risk for Alzheimer’s disease. Ann Neurol 2005;57:381–387.
  55. Bassuk SS, Berkman LF, Wypij D: Depressive symptomatology and incident cognitive decline in an elderly community sample. Arch Gen Psychiatry 1998;55:1073–1081.
  56. Barnes DE, Alexopoulos GS, Lopez OL, Williamson JD, Yaffe K: Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study. Arch Gen Psychiatry 2006;63:273–279.
  57. Solfrizzi V, Panza F, Colacicco AM, D’Introno A, Capurso C, Torres F, Grigoletto F, Maggi S, Del Parigi A, Reiman EM, Caselli RJ, Scafato E, Farchi G, Capurso A, Italian Longitudinal Study on Aging Working Group: Vascular risk factors, incidence of MCI, and rates of progression to dementia. Neurology 2004;63:1882–1891.
  58. Panza F, D’Introno A, Colacicco AM, Capurso C, Del Parigi A, Caselli RJ, Pilotto A, Argentieri G, Scapicchio PL, Scafato E, Capurso A, Solfrizzi V: Current epidemiology of mild cognitive impairment and other predementia syndromes. Am J Geriatr Psychiatry 2005;13:633–644.
  59. Winblad B, Palmer K, Kivipelto M, Jelic V, Fratiglioni L, Wahlund LO, Nordberg A, Bäckman L, Albert M, Almkvist O, Arai H, Basun H, Blennow K, de Leon M, DeCarli C, Erkinjuntti T, Giacobini E, Graff C, Hardy J, Jack C, Jorm A, Ritchie K, van Duijn C, Visser P, Petersen RC: Mild cognitive impairment – beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J Intern Med 2004;256:240–246.
  60. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E: Mild cognitive impairment: clinical characterization and outcome. Arch Neurol 1999;56:303–308.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50